Key Highlights
- Researchers at the University of Texas (UT) at San Antonio, Long School of Medicine, recently discovered that THC (tetrahydrocannabinol, the main psychoactive compound in marijuana) could prevent the development of Alzheimer’s disease – but only when paired with an anti-inflammatory drug called celecoxib. Celecoxib is a selective COX-2 inhibitor that is commonly prescribed for arthritis and pain.
- ALZHEIMER’S DECLINE COULD SLOW DRAMATICALLY WITH ONE SIMPLE DAILY HABIT, STUDY FINDS While THC has previously been shown to have anti-inflammatory and neuroprotective properties, it’s also been linked to negative effects on the brain, particularly in learning and memory, according to a UT Health press release.
- Combining THC with an anti-inflammatory drug, however, could provide the same benefits with fewer negative side effects.
- THC could be powerful against cognitive decline when combined with an anti-inflammatory, a new study suggests.
- (iStock)The study, which was published in the journal Aging and Disease, paired low-dose THC extract with celecoxib, which was administered to mice daily for 30 days.
